Explore more publications!

Press Releases

IR Centers and Urology Associates of Mobile Launch Advanced Interventional Radiology Program in Alabama
Hospital Services Market Size Worth USD 24.17 Trillion by 2034 Driven by Expansion of Digital Health and Telemedicine
Stacia Robinson of BeneChoice Companies LLC Shares Insights on Building Local Business Networks in HelloNation
Attorney General Hanaway Secures Removal Of Corrupt St. Louis Sheriff

Attorney General Hanaway Secures Removal Of Corrupt St. Louis Sheriff

Proactive MD Expands National Value-Based Network with New Acquisitions
Zorts Sports Announces Strategic Partnership With GAME Network to Expand Youth and Amateur Sports Visibility
Mayor Michelle Wu and the Office of Returning Citizens Announce Grant Awards Supporting Programs that Reduce Youth Recidivism

Mayor Michelle Wu and the Office of Returning Citizens Announce Grant Awards Supporting Programs that Reduce Youth Recidivism

The Ensign Group, Inc. Increases Quarterly Dividend to $0.0650 Per Share
United Community Banks, Inc. Announces Date for Fourth Quarter 2025 Earnings Release and Conference Call
Leadership Development Firm Addresses Emotional Demands Facing Modern Leaders
SafeSpace Global Enters Letter of Intent with BMRT for Exclusive Deployment of Molecular-Level Weapons Detection Technology in U.S. Schools and Correctional Facilities
Proactive MD Expands National Value-Based Network with Orthopedic Acquisitions
Gannet BioChem to Participate in Biotech Showcase 2025
Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemistry
Jack Botanicals Best Kratom Brand Unveils Enhanced 2025 Kratom Line
NorthStrive Biosciences Advances to Phase III of AI-Driven Drug Discovery Program Toward Validation of Multiple Potential Drug Compounds & Discoveries
Kymera Therapeutics Announces Closing of Upsized $602 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Dyne Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
Capitol South Founder and CEO Named One of The Hill’s Top Lobbyists for 2025
Kymera Therapeutics Announces Pricing of Upsized $602 Million Public Offering

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions